Senotherapeutics Biomarker Consortium: Inaugural Summit

​The Senotherapeutics Biomarker Consortium (SBC) Inaugural Summit is a landmark scientific gathering convened by the Phaedon Institute — a nonprofit organization dedicated to advancing the science of longevity and cellular senescence through research, education, and cross-sector collaboration.

​This inaugural summit unites leading academics, clinicians, biotechnology executives, and regulatory experts to address one of the most critical challenges in aging biology: the development, standardization, and clinical translation of senescence biomarkers. By bringing together diverse stakeholders across the full translational spectrum, the SBC aims to accelerate the path from mechanistic discovery to actionable clinical tools.

​Program Sessions:

• ​Session 1 — Basic Science & Biomarker Discovery

• ​Session 2 — Clinical Biomarkers & Trials

• ​Session 3 — Therapeutics & Biomarker Integration

• ​Industry Spotlight — Perspectives from Industry Partners

• ​Working Groups — Parallel Breakout Sessions

• ​Perspectives — Regulation & Funding Landscape

• ​Round Table — Where Does the Field Go From Here?

• ​Focused Networking Event

​Hosts & Organizers:

• ​Marco Demaria — ERIBA, University of Groningen

• ​Vidyani Suryadevara — Stanford University

• ​Nicola Neretti — Brown University

• ​Heinrich Jasper — Genentech, Inc.

• ​Marco Quarta — Rubedo Life Sciences, Inc.

​For full program details, visit phaedon.institute/sbc/ or phaedon.institute/summit/sbc-2026/ or contact [email protected]